Drug application
ICATIBANT ACETATE (ICATIBANT ACETATE)
Drugs@FDA ANDA 211501 · WILSHIRE PHARMS INC
Key facts
| Drug name | ICATIBANT ACETATE |
|---|---|
| Active ingredients | ICATIBANT ACETATE |
| Application type | ANDA |
| Application number | 211501 |
| Company | WILSHIRE PHARMS INC |
| Dosage forms | INJECTABLE, SUBCUTANEOUS |
| Strength | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | Sep 2, 2020 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.